| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/28/2002 | WO2002024337A1 Multiple analyte assay device with sample integrity monitoring system |
| 03/28/2002 | WO2002024325A2 Acoustic ejection of fluids from a plurality of reservoirs |
| 03/28/2002 | WO2002024324A2 Focused acoustic energy in the preparation and screening of combinatorial libraries |
| 03/28/2002 | WO2002024323A2 High density molecular arrays on porous surfaces |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024204A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 03/28/2002 | WO2002024177A2 Methods of identifying inhibitory compounds and uses thereof |
| 03/28/2002 | WO2002024146A2 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/28/2002 | WO2002024144A2 Use of transcription factors for treating inflammation and other diseases |
| 03/28/2002 | WO2002024071A2 Method, apparatus and system for assessing hair condition |
| 03/28/2002 | WO2002014869A3 Assay method and device for detecting the presence and concentration of analytes |
| 03/28/2002 | WO2002013598A3 Fish hatching method and apparatus |
| 03/28/2002 | WO2002004484A3 Hcv mosaic antigen composition |
| 03/28/2002 | WO2002000918A3 Biosensor and method for production thereof |
| 03/28/2002 | WO2001096601A3 Neurotransmission disorders |
| 03/28/2002 | WO2001095059A3 A method and system for populating a database |
| 03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |
| 03/28/2002 | WO2001092615A3 Method for controlling a texturing machine, and texturing machine |
| 03/28/2002 | WO2001091903A3 Self-contained devices for detecting biological contaminants |
| 03/28/2002 | WO2001090759A3 Diagnostic method for hyperinsulinism of infancy based on detecting altered k-atp channels |
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001089361A3 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 03/28/2002 | WO2001088847A3 Lead molecule generation |
| 03/28/2002 | WO2001088538A8 Compositions and methods for epitope mapping |
| 03/28/2002 | WO2001088177A3 Stain solution, which is devoid of phenol, for bacteria |
| 03/28/2002 | WO2001088087A3 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation |
| 03/28/2002 | WO2001086305A3 Identification of modulators of gpr55 activity |
| 03/28/2002 | WO2001086258A3 Pd/ni-wo3 anodic double layer colormetric gas sensor |
| 03/28/2002 | WO2001085985A8 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001080719A3 Methods and composition for the diagnosis of schizophrenia |
| 03/28/2002 | WO2001080711A3 Method of evaluating a risk of a subject of developing vascular complications |
| 03/28/2002 | WO2001079522A3 Screening assay methods and systems using target pooling |
| 03/28/2002 | WO2001079249A3 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001073126A3 Diagnostic devices containing porous material |
| 03/28/2002 | WO2001073114A3 Reagents and methods for detecting a reduced cofactor |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001069247A3 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells |
| 03/28/2002 | WO2001069199A3 Methods of detecting cancer using cellular autofluorescence |
| 03/28/2002 | WO2001068839A3 Regulation of human lipoxin a4 receptor-like protein |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001065257A3 Method for the analysis of exogenic and endogenic cell activation |
| 03/28/2002 | WO2001064945A3 Novel dna chips |
| 03/28/2002 | WO2001063296A3 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient |
| 03/28/2002 | WO2001063292A3 Compositions and methods of use of het, a novel modulator of estrogen action |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001061360A3 Identification of modulators of gpr31 activity |
| 03/28/2002 | WO2001061359A3 Identification of modulators of gpr41 or gpr42 activity |
| 03/28/2002 | WO2001059156A3 DETECTION OF BINDING OF CHARGED SPECIES USING pH- OR POTENTIAL-SENSITIVE PROBES |
| 03/28/2002 | WO2001058476A3 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001055047A3 Assay methods for hydratable cementitious compositions |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001036674A3 Diagnostic methods for detection of prostate disorders |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001019353A3 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000070088A3 Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| 03/28/2002 | WO2000063419A9 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 03/28/2002 | WO2000062833A9 Cellular matrix system and use thereof |
| 03/28/2002 | WO2000051520A9 Bovine pregnancy testing |
| 03/28/2002 | WO2000049417A9 Methods for substrate-ligand interaction screening |
| 03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | WO2000043791A9 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 03/28/2002 | WO2000042912A9 Polarized light scattering spectroscopy of tissue |
| 03/28/2002 | US20020038471 Use of VLCFAE for identifying herbicidally active compounds |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038464 Novel glucose transporter/sensor protein and uses thereof |
| 03/28/2002 | US20020038463 Methods for screening and identifying host pathogen defense genes |
| 03/28/2002 | US20020038184 Methods and systems for estimating binding affinity |
| 03/28/2002 | US20020038016 Decoy probes |
| 03/28/2002 | US20020038015 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037999 Coiled-coil mediated heterodimerization functional interaction trap |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037868 Diagnosis using antibodies |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037847 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 03/28/2002 | US20020037843 Method and composition for modulating amyloidosis |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037839 Antiischemic agents; hypotensive agents; antiiflammatory agents |
| 03/28/2002 | US20020037594 Support for use in the immunological detection, separation and analysis of preferenial particles |
| 03/28/2002 | US20020037593 Diffraction-based cell detection using a micro-contact-printed antibody grating |
| 03/28/2002 | US20020037592 Receptor-based assays for pathogens |
| 03/28/2002 | US20020037591 Composition for measuring trace amount of protein |
| 03/28/2002 | US20020037589 Detection of nucleic acids in red blood cells by flow cytometry by employing fluorescent, nucleic acid binidng cyanine dye |
| 03/28/2002 | US20020037585 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037565 Purifying and quantifying adenovirus by ion-exchange chromatography; for example, identifying different adenovirus serotypes |